Table 1.
Summary of three reported cases of skull metastases from uterine leiomyosarcoma.
| Authors/ year | Age at uLMS diagnosis | Adjuvant treatment after surgery of primary tumor | Interval from diagnosis of primary lesion to brain metastasis (months) | Site | Surgery | Adjuvant treatment after cranial surgery | 1st line CHT | Interval from brain metastasis to death (months) |
|---|---|---|---|---|---|---|---|---|
| Uchino et al. (16) | 49 | Not performed | 60 | Frontal bone | R0 resection | Adriamycin, Vincristine, Cisplatin | No | 24 |
| Yip et al. (17) | 62 | CHT (schedule not specified) | 15 | Left parietal bone | R0 resection | Not performed | No | 4 (not uLMS-related death) |
| Present report | 38 | Epirubicine—Ifosfamide | 18 | Right temporal—occipital bone | R1 resection | Radiation therapy (3,500 cGy in five fractions of 700 cGy) | No | NA |
uLMS, uterine leiomyosarcoma; CHT, chemotherapy; R0, radical surgery, with no cancer cells seen microscopically at the resection margin; R1, cancer cells present microscopically at the resection margin (microscopic positive margin); NA, not available; cGy, centiGray.